Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells.

The nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP-1), which was initially known to be highly activated by oxidative stress-induced DNA strand breaks, has been shown to be involved in the pathophysiology of acute and chronic inflammatory diseases. PARP-1 deficiency in mice led to the discovery of its coactivating function in the nuclear factor-kappa B-mediated gene expression and in addition, pharmaceutical inhibition of PARP-1 was shown to reduce the production of inflammatory mediators. In this study, the in vitro PARP-1-inhibiting effect of various flavonoids was investigated. The flavonoids myricetin, tricetin, gossypetin, delphinidin, quercetin, and fisetin were identified as significant inhibitors of the purified enzyme. Further evaluation of these compounds in N-methyl-N'-nitro-N-nitrosoguanidine-treated human pulmonary epithelial cells showed that the formation of the poly(ADP-ribose) polymers, as well as the decreased NAD(+) levels, was reduced by quercetin, fisetin, and tricetin. Finally, IL-8 production of LPS-stimulated human pulmonary epithelial cells could be significantly reduced by these flavonoids. The results of this study indicate that specific flavonoids have PARP-1-inhibiting activity in addition to the earlier described antioxidant effects. PARP-1 inhibition and preservation of cellular NAD(+) and energy production could play a role in the antiinflammatory activity of these specific flavonoids. In addition, these results indicate additional mechanisms by which flavonoids can exert antiinflammatory activity. Furthermore, these results indicate possibilities to use food-derived flavonoids in the treatment of chronic inflammatory diseases.

[1]  D. Acosta,et al.  Evaluation of cytotoxicity in cultured cells by enzyme leakage , 1980 .

[2]  P. Goulding,et al.  Polyphenol complexation—some thoughts and observations , 1988 .

[3]  D Kromhout,et al.  Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. , 1993, Nutrition and cancer.

[4]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[5]  K. Matsushima,et al.  Molecular mechanism of interleukin‐8 gene expression , 1994, Journal of leukocyte biology.

[6]  P. Hollman,et al.  Absorption and disposition kinetics of the dietary antioxidant quercetin in man. , 1996, Free radical biology & medicine.

[7]  C. Rice-Evans,et al.  Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.

[8]  P. Hollman,et al.  Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man , 1997, FEBS letters.

[9]  P. Hollman,et al.  Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. , 1997, Cancer letters.

[10]  P. Chambon,et al.  Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Jacobson,et al.  Tissue NAD as a biochemical measure of niacin status in humans. , 1997, Methods in enzymology.

[12]  P. Hollman,et al.  Absorption, metabolism and health effects of dietary flavonoids in man. , 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  B. Holub,et al.  Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. , 1998, The Journal of nutrition.

[14]  M. Hottiger,et al.  A Role of Poly (ADP-Ribose) Polymerase in NF- B Transcriptional Activation , 1999 .

[15]  E. A. Miranda,et al.  An improved nonisotopic test to screen a large series of new inhibitor molecules of poly(ADP-ribose) polymerase activity for therapeutic applications. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  R. Andriantsitohaina,et al.  Resistance to endotoxic shock as a consequence of defective NF‐κB activation in poly (ADP‐ribose) polymerase‐1 deficient mice , 1999, The EMBO journal.

[17]  M. Hottiger,et al.  A role of poly (ADP-ribose) polymerase in NF-kappaB transcriptional activation. , 1999, Biological chemistry.

[18]  G. Poirier,et al.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. , 1999, The Biochemical journal.

[19]  V. Schreiber,et al.  Base excision repair is impaired in mammalian cells lacking Poly(ADP-ribose) polymerase-1. , 2000, Biochemistry.

[20]  B. Fanburg,et al.  Reactive oxygen species in cell signaling. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[21]  K. Murthy,et al.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.

[22]  W. Chang,et al.  The Sequence-specific DNA Binding of NF-κB Is Reversibly Regulated by the Automodification Reaction of Poly (ADP-ribose) Polymerase 1* , 2001, The Journal of Biological Chemistry.

[23]  M. Perretti,et al.  Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase , 2001, Inflammation Research.

[24]  A. Bast,et al.  Masking of antioxidant capacity by the interaction of flavonoids with protein. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[25]  W. MacNee,et al.  Oxidative stress and lung inflammation in airways disease. , 2001, European journal of pharmacology.

[26]  D. Barron,et al.  Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin , 2001, Free radical research.

[27]  M. Covic,et al.  The Enzymatic and DNA Binding Activity of PARP-1 Are Not Required for NF-κB Coactivator Function* , 2001, The Journal of Biological Chemistry.

[28]  E. van Nood,et al.  Flavonoids: a review of probable mechanisms of action and potential applications. , 2001, The American journal of clinical nutrition.

[29]  C. Szabó,et al.  Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. , 2002, American journal of respiratory and critical care medicine.

[30]  I. Rahman.  Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. , 2002, Biochemical pharmacology.

[31]  F. Gallyas,et al.  Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents* , 2002, Critical care medicine.

[32]  E. Rimm,et al.  Flavonol and flavone intakes in US health professionals. , 2002, Journal of the American Dietetic Association.

[33]  S. Mori,et al.  Poly(ADP-Ribose) Polymerase Impairs Early and Long-Term Experimental Stroke Recovery , 2002, Stroke.

[34]  Janice A. Brown,et al.  Development of a high-throughput screening-amenable assay for human poly(ADP-ribose) polymerase inhibitors. , 2002, Journal of pharmacological and toxicological methods.

[35]  E. Wouters,et al.  Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. , 2003, Free radical biology & medicine.

[36]  A. Boulares,et al.  Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma. , 2003, American journal of respiratory cell and molecular biology.

[37]  T. Helleday,et al.  Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination. , 2003, Nucleic acids research.

[38]  A. Goetz,et al.  Role of PARP on iNOS pathway during endotoxin-induced acute lung injury , 2004, Intensive Care Medicine.

[39]  Wei‐Chien Huang,et al.  Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships. , 2004, Molecular pharmacology.

[40]  C. Szabó,et al.  Gallotannin Inhibits the Expression of Chemokines and Inflammatory Cytokines in A549 Cells , 2005, Molecular Pharmacology.

[41]  E. Wouters,et al.  Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations. , 2006, Biochemical pharmacology.

[42]  Fermín Sánchez de Medina,et al.  Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. , 2006, Biochemical pharmacology.

[43]  P. Radermacher,et al.  THE PARP-1 INHIBITOR INO-1001 FACILITATES HEMODYNAMIC STABILIZATION WITHOUT AFFECTING DNA REPAIR IN PORCINE THORACIC AORTIC CROSS-CLAMPING-INDUCED ISCHEMIA/REPERFUSION , 2006, Shock.

[44]  Ravikumar Aalinkeel,et al.  The Flavonoid Quercetin Inhibits Proinflammatory Cytokine (Tumor Necrosis Factor Alpha) Gene Expression in Normal Peripheral Blood Mononuclear Cells via Modulation of the NF-κβ System , 2006, Clinical and Vaccine Immunology.